An inexpensive two-drug regimen of sofosbuvir (Sovaldi, Gilead Sciences) plus daclatasvir (Daklinza, Bristol-Myers Squibb) taken for 14 days significantly reduced time to recovery from COVID-19 and improved survival in people hospitalized with severe disease,…
Highlights: Fruits and vegetables need to be washed after you buy themFruits and vegetables should be put in water for a few minutes with a 50 ppm drop of chlorine…
The US Food and Drug Administration has approved fostemsavir (Rukobia, ViiV Healthcare), a first-in-class attachment inhibitor for the treatment of HIV-1 infection in adults. Fostemsavir is indicated for use in…
COVID-19 concerns should not stop patients from using inhaled corticosteroids, a new commentary article suggests. While patients with pulmonary diseases are at increased risk of developing COVID-19, those treatments may…
A new combination of biomarkers from baseline tumor tissues was predictive of improved clinical responses and prolonged survival following treatment with immune checkpoint inhibitors in patients with advanced metastatic bladder…
The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children at least 4 weeks old and…
